ArticleSignal transduction and targeted therapy2020

Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma.

Hongyan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.